Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

TELA Bio (TELA) Change in Intangibles (2019)

TELA Bio has reported Change in Intangibles over the past 1 years, most recently at $2.0 million for Q3 2019.

For Q3 2019, Change in Intangibles changed N/A year-over-year to $2.0 million; the TTM value through Dec 2019 reached $2.5 million, changed N/A, while the annual FY2022 figure was $1.0 million, N/A changed from the prior year.
Change in Intangibles for Q3 2019 was $2.0 million at TELA Bio, up from $500000.0 in the prior quarter.
Over five years, Change in Intangibles peaked at $2.0 million in Q3 2019 and troughed at $500000.0 in Q1 2019.